Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B

Phase 2 Completed 209 enrolled Chongqing Jiachen Biotechnology Ltd. Third Military Medical University · collab

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose is to evaluate efficacy and safety of therapeutic HBV vaccine (mimogen-based) treatment in chronic hepatitis B patients and to explore the most effective dosage and provide the rational for optimal dosing schedule.

Timeline

Start: 2010-09
Primary completion: 2013-03
Completion: 2013-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	εPA-44	Vaccine	900 ug	Subcutaneous

Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B

Summary

Timeline

Drugs

Indications